Lexiva/Telzir

Lexiva/Telzir (fosamprenavir) is a protease inhibitor.

Canada Resources for Canadian residents/Ressources pour les résidants du Canada

Safety Information / Renseignements sur l’innocuité

US Resources for US residents

UK/EU Resources for UK/EU residents

Patient Information Leaflets

Summary of Product Characteristics

US Resources for Japanese residents

Other resources


Report a side effect

 
To report a suspected side effect, please use our online reporting form. This facility is provided under our service agreement with GlaxoSmithKline (GSK), so you will need to choose ‘ViiV Healthcare medicines’ from the drop-down product list on the form. In North America, you can report a side effect via the GSK Response Center at 1-888-825-5249, Monday-Friday, 8am - 8pm ET.

Get Adobe Reader Most computers will open PDF documents automatically, but you may need to download Adobe Reader.

© 2012 ViiV Healthcare group of companies. All rights reserved